MATR Sponsor:


MATR Supporters:

Montana Biotech News


New Law Likely to Prompt Boom in Biotech Research, Funding:


Clocking in at nearly 1,000 pages, the 21st Century Cures Act is deemed one of the most comprehensive laws Congress has passed since the Affordable Care Act was adopted in 2010. by John Murawski Full ...


Butte's BioScience Laboratories gives public a peek inside:


The folks at BioScience Laboratories https://www.biosciencelabs.com/ want you to know: they don't turn people green. That's what BioScience marketing coordinator Britt Kapperud told The Montana Standard ...


New Biotech Company Inimmune Formed at University of Montana's MonTEC Business Incubator:


Officials from a new biotech company, Inimmune Corporation http://inimmune.com/ , met with Gov. Steve Bullock today to discuss how the University of Montana connects researchers and entrepreneurs ...


Thinking of crowdfunding your science? Study suggests some tips:


Thinking small, being engaging, and having a sense of humor don't hurt. Those are a few of the traits of successful science crowdfunding efforts that emerge from a recent study that examined nearly 400 ...


Bozeman Takeda branch involved with push for Zika vaccine:


Takeda announced Thursday it had received $19.8 million from the U.S. Department of Health and Human Services to develop the vaccine, with a first phase of clinical trials set for 2017. It also says ...


In search of a cure: Upstart Missoula biotech company Inimmune on the cutting edge of science:


In a collection of small laboratories filled with glass beakers, liquid compounds and deep freezers, scientists with the upstart Missoula biotech firm Inimmune http://inimmune.com/ are looking to cure ...


How a Decision by a Major Company is Going to Have a Very Positive Impact on Missoula, Montana's Economy:


Jay Evans http://hs.umt.edu/dbs/people/researchLecturers.php?s=Evans4801 was surprised when he got the call. His employer of 15 years, GlaxoSmithKline, had decided to reorganize and close its ...


Montana initiative seeks funds for biomedical research:


Signature collection has been approved by the secretary of state for an initiative for the Nov. 8 ballot that will issue as much as $200 million in bonds over 10 years to fund Montana-based biomedical ...


Belgrade,Montana -based Bacterin to acquire Ohio firm, rebrand as Xtant Medical Holdings Inc. in $88-million deal:


Combines Belgrade-based biotech company Bacterin's http://bacterin.com/ strength in orthobiologics with X-spine's expertise in hardware offering complementary product lines focused on orthopedic and spine ...


Bozeman biotech industry takes a breath at Takeda announcement, but continued growth likely:


The biotechnology industry in Montana might be small, and it may be fragile. But it's probably not going away any time soon. With the recent announcement that Takeda plans to close its vaccine facility ...


Montana Bioscience-Innovators Networking Reception, 5/5, Missoula, Montana:


Please join us for an inaugural Montana Bioscience Innovators Networking Reception. Come learn what your peers are doing in region and enjoy some great food and drinks. The focus of this meeting ...


FDA approves the first biosimilar for the U.S. market:


Biosimilars have been circulating in Europe since 2006. Now the U.S. can reap the benefits. The U.S. Food and Drug Administration approved the first biosimilar for U.S. markets Friday, a decision that ...


Submittable 2014 Year in Review: Custom Forms, API, Mobile, and John Wayne Slept Here:


You can do things in hotels you wouldn't necessarily do at home. When asked, my 8-year-old said the most obvious thing you'd do at a hotel that you wouldn't do at home is jump on the bed. After some ...


Study Ranks Life Sciences Industry Clusters:




University of Montana research proves that a small dose of medical methamphetamine might go a long way in limiting post-TBI brain damage - Sinapis Pharma raising funds for Trials:


A mistake made by a PhD student in a University of Montana lab nearly a decade ago is now on the brink of mid-stage clinical trials as a potential treatment for traumatic brain injuries. And, most ...


Settling a New Biotech Frontier in Montana - Montana Molecular:


"If you start a biotech company in Montana, the governor and our senators take notice and will help with networking opportunities. If you are awarded an SBIR, the state of Montana will kick in matching ...


Governor Bullock Announces Crohn's Disease Bio-Medical Research Grant Award to Billings' Health Partners:


Funding will support the newly-established Crohn's Disease Collaborative Research Center Governor Steve Bullock and Department of Commerce Director Meg O'Leary announced the award of $95,500 ...


Governor Bullock Announces Bio-Medical Research Grant Award to McLaughlin Research Institute:


Funding will help establish research capabilities at a Montana Center for Aging Research and Memory Care Governor Steve Bullock announced the award of $904,500 dollars in grant funding ...


CDC Threat Report: 'We Will Soon Be in a Post-Antibiotic Era' :


The U.S. Centers for Disease Control and Prevention has just published a first-of-its-kind assessment of the threat the country faces from antibiotic-resistant organisms, ranking them by the number of ...


Glaxo to Get Up to $200 Million From U.S. for Biothreat Research:


GlaxoSmithKline Plc (GSK), the U.K.'s largest drugmaker, will work with the U.S. government to develop antibiotics for resistant infections and bioterrorist threats in an agreement valued at as much as ...


Bacterin CEO Guy Cook to step down:


Bacterin International http://bacterin.com/ announced Monday that president and CEO Guy Cook has decided to step down from his role with the Belgrade biotechnology company. Cook will remain with ...


Montana Governor Steve Bullock makes pitch for future vaccine factory at LigoCyte in Bozeman:


Gov. Steve Bullock came to Bozeman on Friday to demonstrate Montana's keen interest in being chosen when executives decide where to build a multimillion-dollar manufacturing plant for the vaccine ...


Welcome to The National Institutes of Health Director's Blog!:


I'm starting this blog http://directorsblog.nih.gov/ to highlight new discoveries in biology and medicine that I think are game changers, noteworthy, or just plain cool. Depending on what's going ...


Bozeman, Montana based SensoPath Technologies gets contract to continue cancer research:


Local biotechnology company SensoPath Technologies http://www.sensopath.com/ has received a $1.5 million contract from the National Cancer Institute at the National Institutes of Health. The contract ...


GSK to open clinical data vaults to scientists via website:


GlaxoSmithKline ($GSK) committed to provide researchers with unmatched access to patient-level data from its clinical trials--including studies that failed. The move is among several steps the London-based ...


New technology from Bozeman, Montana's Montana Molecular may speed medical research:


Drug development can be a long and expensive process. Even after years of research and testing, a new drug can run into unexpected problems that can render all the time and money put into the development ...


Montana BioScience Alliance July 2012 Newsletter:


Articles of Interest Billings Clinic May 2012 Golden Helix Establishes Direct Presence in Japan Guest Opinion - Billings Gazette JOBS Act a positive step for Montana business ...


New JOBS law expected to boost Bozeman, Montana biotechs:


Bozeman-based Microbion has created one of only a few new classes of antibiotics in the last 30 years, a yellowish, powdery compound manufactured off South 19th Avenue. It works against biofilms, ...


Glaxo and J&J's New €150MM Fund Will Help the Biotech Ecosystem :


Index Ventures made news recently when it announced a new €150 million fund to invest in early-stage, life science companies. With many venture firms scaling back or exiting the business entirely, any ...


Frazier Looks to Build Biotechs For Sale, Lay Groundwork for First Post-Crisis Fund:


Alan Frazier has been on record for a long time saying that the traditional biotech venture model is broken, and in severe need of updating. He's been working on a new strategy for the past seven years ...

View ALL Montana Biotech news



Reprinted under the Fair Use doctrine of international copyright law. Full copyright retained by the original publication. In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes.


E-mail this page to a friend!